Now a hot topic among both experts and casual users alike, generative artificial intelligence has made its mark on the world. Its recent explosion in popularity came along with the rise of ChatGPT, an OpenAI-developed chatbot that can generate text and images based on user prompts.
Though the federal government has been experimenting with automation for many years, GenAI has brought about new opportunities for AI across a wide range of use cases. At the Potomac Officers Club’s 5th Annual CIO Summit on April 17, you will have the chance to hear leaders from across the public and private sectors share their insights on the ways in which the U.S. government is leveraging GenAI.
To learn more and register for the event, click here.
The summit will feature two panels on GenAI, one of which will focus on the technology’s impact on information technology modernization. Robert McNamara, a partner at Guidehouse who leads the firm’s digital solutions and IT strategy practice, will moderate this panel.
McNamara is a strong supporter of GenAI. In a recent LinkedIn post, he wrote that even in its early stages, the technology “is already showing promise in driving fundamental changes at our healthcare clients.”
Thoughtful development, he continued, “can accelerate moving towards scaled solutions.”
On Tuesday, Guidehouse released a survey done in collaboration with CDO Magazine on organizational readiness for GenAI. Responses were gathered from both public and private sector executives. While many respondents showed interest in GenAI projects, only eight percent of government leaders expressed GenAI readiness. The survey also found healthcare to be one of the fields most willing to embrace GenAI.
According to McNamara, who shared a blog post by fellow Guidehouse Partner Brian Jones on LinkedIn, “Guidehouse digital and health IT experts are exploring the impact of GenerativeAI on providers, clinicians and patients.”
The blog post highlighted four key areas in which GenAI can be used in healthcare: personalized medicine, drug development and clinical trials, screening and diagnosis and predictive maintenance.
Don’t miss out on the opportunity to hear more of McNamara’s thoughts in an intriguing panel discussion! Secure your spot at the 5th Annual CIO Summit here.
